Candida albicans is a major fungal pathogen of humans. It exists as a commensal in the oral
cavity, gut or genital tract of most individuals, constrained by the local microbiota, epithelial …

Candida albicans infections range from superficial to systemic and are one of the leading
causes of fungus-associated nosocomial infections. The innate immune responses during …

The fungus Candida albicans is an opportunistic pathogen that can exploit imbalances in
microbiome composition to invade its human host, causing pathologies ranging from vaginal …

Vulvovaginal candidiasis is a vaginal infection caused by the fungal pathogen Candida
albicans that, most commonly, affects women of reproductive age. Its first-line treatment …

Background Vaginal candidiasis is frequent in women of reproductive age. Accurate
identification Candida provides helpful information for successful therapy and epidemiology …

The different Lactobacillus strains of probiotics have been applied to the treatment and
prevention of bacterial vaginosis and vulvovaginal candidiasis. The experimental data …

The poor solubility of itraconazole (ITZ) has limited its efficacy in the treatment of vaginal
candidiasis. Accordingly, the improvement of ITZ solubility using a solid dispersion …

In recent years, a progressive increase in the incidence of invasive fungal infections (IFIs)
caused by Candida glabrata has been observed. The objective of this literature review was …

Infectious microbes that spread easily in healthcare facilities remain as the severe threat for
the public health, especially among immunocompromised populations. Given the intricate …

Vaginal administration is a promising route for the local treatment of infectious vaginal
diseases since it can bypass the first-pass metabolism, drug interactions, and adverse …